Clinical trial

The Effect of Inhaled Nitric Oxide on Pulmonary Gas-exchange in COPD

NCT04231760

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention Inhaled Nitric Oxide Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Placebo Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

The Effect of Inhaled Nitric Oxide on Pulmonary Gas-exchange in COPD

Design: INTERVENTIONAL · Status: NOT YET RECRUITING · Phase: PHASE1, PHASE2

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusNOT_YET_RECRUITING

Study typeINTERVENTIONAL

Start date2026-12-01

PhasePHASE1 / PHASE2

Conditions

Chronic Obstructive Pulmonary Diseaseverified · MONDO: chronic obstructive pulmonary disease

Interventions

Inhaled Nitric OxideDRUG

PlaceboDRUG

Sponsors & collaborators

University of Albertalead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04231760 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.